- 2018 - 2022 Development of a new diagnostic method for pediatric HSPN using urinary biomarkers
- 2015 - 2019 Establishment of new diagnostic biomarker for childhood IgA nephropathy
- 2015 - 2018 Development of disease specific therapy based on pathophysiology of IgA nephropathy focusing on microRNA
- 2014 - 2017 Development of disease specific therapy based on microRNA in polycystic kidney disease
- 2013 - 2016 A new trial of moleular genetics for the onset of Kawasaki disease
- 2012 - 2015 Functional mechanism of cyclosporin A therapy for immunoglobulin-resistant Kawasaki disease
- 2012 - 2015 Role of imflammasome in IgA nephropathy
- 2011 - 2013 Disease specific therapy of polycystic kidney disease based on its pathophysiology considering the ubiquitin-proteasome proteolysis mechanism
- 2008 - 2010 Epithelial-to-mesenchymal transition (EMT) in polycystic kidney disease
- 2007 - 2009 Strategy for neonatal chronic lung disease : Prevention from lung fibrosis with NO inhalation
- 2006 - 2007 Genetic analysis of glomerular podocyte molecules in children with nephrotic syndrome
- 2005 - 2007 Analysis of NPHS1, NPHS2, ACTN4, WT1 and CD2AP in Japanese patients with congenital nephrotic syndrome
- 2003 - 2004 Genetic analysis in children with Escherichia coli O157-associated hemolytic uremic syndrome
- 2002 - 2004 Analysis of NPHS1, NPHS2, ACTN4 and WT1 in Japanese patients with congenital nephrotic syndrome
- 1990 - 1992 Glomerular basement membrane permeability factor in minimal change nephrotic syndrome
- 1986 - 1986 小児期IgA腎症,紫斑病性腎炎の免疫病理学的研究
- 1984 - 1984 小児期糸球体腎炎の免疫病理学的研究
- 小児腎臓病
Show all